Showing posts with label mortality. Show all posts
Showing posts with label mortality. Show all posts

Tuesday, 13 September 2022

 

Current and future burden of breast cancer: Global statistics for 2020 and 2040

 

by Melina Arnold, Eileen Morgan, Harriet Rumgay, Allini Mafra, Deependra Singh, Mathieu Laversanne, Jerome Vignat, Julie R. Gralow, Fatima Cardoso, Sabine Siesling, Isabelle Soerjomataram 

 

The Breast: September 01, 2022

 

Background

Breast cancer is the most commonly diagnosed cancer worldwide, and its burden has been rising over the past decades. In this article, we examine and describe the global burden of breast cancer in 2020 and predictions for the year 2040.

Methods

Estimates of new female breast cancer cases and deaths in 2020 were abstracted from the GLOBOCAN database. Age-standardized incidence and mortality rates were calculated per 100,000 females by country, world region, and level of human development. Predicted cases and deaths were computed based on global demographic projections for the year 2040.

Results

Over 2.3 million new cases and 685,000 deaths from breast cancer occurred in 2020. Large geographic variation across countries and world regions exists, with incidence rates ranging from <40 per 100,000 females in some Asian and African countries, to over 80 per 100,000 in Australia/New Zealand, Northern America, and parts of Europe. Smaller geographical variation was observed for mortality; however, transitioning countries continue to carry a disproportionate share of breast cancer deaths relative to transitioned countries. By 2040, the burden from breast cancer is predicted to increase to over 3 million new cases and 1 million deaths every year because of population growth and ageing alone.

Conclusion

Breast cancer is the most common cancer worldwide and continues to have a large impact on the global number of cancer deaths. Global efforts are needed to counteract its growing burden, especially in transitioning countries where incidence is rising rapidly, and mortality rates remain high.

Tuesday, 16 November 2021

 

National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis

by Catherine Duggan, Dario Trapani, AndrĂ© M Ilbawi, Elena Fidarova, Mathieu Laversanne, Giuseppe Curigliano, Freddie Bray, Benjamin O Anderson 

 

The Lancet Oncology: ARTICLES| VOLUME 22, ISSUE 11, P1632-1642, NOVEMBER 01, 2021

 

Countries with low breast cancer mortality rates are characterised by increased levels of coverage of essential health services and higher numbers of public cancer centres. Among countries achieving sustained mortality reductions, the majority of breast cancers are diagnosed at an early stage, reinforcing the value of clinical early diagnosis programmes for improving breast cancer outcomes.

Thursday, 17 May 2018

[News] No impact of English national cancer policies on survival




[News] No impact of English national cancer policies on survival

The Lancet Oncology by Talha Khan Burki  Published: 22 March 2018

A new study has concluded that the 2000 NHS Cancer Plan and subsequent national cancer policy strategies did not reduce socio-economic inequalities in cancer survival or improve cancer survival overall in England.

Tuesday, 7 February 2012

The decline in breast cancer mortality in Europe

The decline in breast cancer mortality in Europe: An update to 2009. The Breast, Vol. 21(1), Feb. 2012, p. 77-82.

Bosetti, C., et al.

http://www.sciencedirect.com/science/article/pii/S0960977611001688

We updated trends in breast cancer mortality in Europe up to the late 2000’s. In the EU, age-adjusted (world standard population) breast cancer mortality rates declined by 6.9% between 2002 and 2006, from 17.9 to 16.7/100,000. The largest falls were in northern European countries, but more recent declines were also observed in central and eastern Europe.